Cargando…

Immune profile analysis of peripheral blood and tumors of lung cancer patients treated with immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) have become central to lung cancer drug therapy, and establishing biomarkers that can predict effects and adverse events (AEs) is awaited. We prospectively analyzed the association between the immune-related molecular expression in peripheral blood mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ichiki, Yoshinobu, Fukuyama, Takashi, Ueno, Mari, Kanasaki, Yoshiro, Goto, Hidenori, Takahashi, Mai, Mikami, Shuji, Kobayashi, Noritada, Nakanishi, Kozo, Hayashi, Shinichi, Ishida, Tsuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742629/ https://www.ncbi.nlm.nih.gov/pubmed/36519023 http://dx.doi.org/10.21037/tlcr-22-421

Ejemplares similares

An analysis of the immunological tumor microenvironment of primary tumors and regional lymph nodes in squamous cell lung cancer
por: Ichiki, Yoshinobu, et al.
Publicado: (2021)

Relationship between Kita-Kyushu Lung Cancer antigen-1 expression and prognosis of cases with lung squamous cell carcinoma
por: Ichiki, Yoshinobu, et al.
Publicado: (2021)

Utilizing the chest tube insertion site as the site of initial trocar insertion with an optical-access trocar in video-assisted thoracoscopic surgery for spontaneous pneumothorax
por: Goto, Hidenori, et al.
Publicado: (2022)

The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung
por: Ichiki, Yoshinobu, et al.
Publicado: (2020)

Should Lung-Sparing Surgery Be the Standard Procedure for Malignant Pleural Mesothelioma?
por: Ichiki, Yoshinobu, et al.
Publicado: (2020)

Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen
por: Futawatari, Nobue, et al.
Publicado: (2017)

Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors
por: Kurozumi, Atsumasa, et al.
Publicado: (2021)

Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers
por: Shida, Akiko, et al.
Publicado: (2020)

Two Types of Immune Checkpoint Inhibitor-related Pancreatitis
por: Ichiki, Tomoko, et al.
Publicado: (2021)

Effects of immune checkpoint inhibitor therapy resumption in patients with malignant tumors after moderate-to-severe immune-related adverse events
por: Kawahira, Machiko, et al.
Publicado: (2022)

Fatal Immune Checkpoint Inhibitor-related Pancreatitis
por: Ueno, Masayuki, et al.
Publicado: (2021)

Expression of KK-LC-1, a cancer/testis antigen, at non-tumour sites of the stomach carrying a tumour
por: Fukuyama, Takashi, et al.
Publicado: (2018)

A New Index for the Quantitative Evaluation of Surgical Invasiveness Based on Perioperative Patients’ Behavior Patterns: Machine Learning Approach Using Triaxial Acceleration
por: Nakanishi, Kozo, et al.
Publicado: (2023)

Immune checkpoint inhibitors for treatment of small-cell lung cancer: a systematic review and meta-analysis
por: Niu, Zhicheng, et al.
Publicado: (2021)

Detection of Kita-Kyushu Lung Cancer Antigen-1, a Cancer/Testis Antigen, in the Stomach Close to a Cancerous Condition
por: Otsuka, Toshikazu, et al.
Publicado: (2022)

A case of napsin A-positive metastatic lung cancer originating from the colon
por: Ito, Tomokazu, et al.
Publicado: (2017)

Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjects
por: Iwamoto, Yuichiro, et al.
Publicado: (2023)

The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
por: Komura, Kazumasa, et al.
Publicado: (2023)

Immune-related adverse events with immune checkpoint inhibitors: Special reference to the effects on the lungs
por: Hirata, Aya, et al.
Publicado: (2021)

Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
por: Murayama, Aiko, et al.
Publicado: (2021)

Imaging findings of primary hepatic carcinoid tumor with an emphasis on MR imaging: case study
por: Ichiki, Makoto, et al.
Publicado: (2014)

Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
por: Haratani, Koji, et al.
Publicado: (2020)

Severe immune checkpoint inhibitor-associated gastritis: A case series and literature review
por: Sugiyama, Yuya, et al.
Publicado: (2022)

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
por: Bertucci, François, et al.
Publicado: (2021)

Radiological imaging features of the salivary glands in xerostomia induced by an immune checkpoint inhibitor
por: Katsura, Kouji, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Therapy: A Boon to Elderly Patients with Advanced Melanoma?
por: Muta, Tsuyoshi
Publicado: (2018)

Immune checkpoint inhibitors
por: Hui, Enfu
Publicado: (2019)

Immune checkpoint inhibitors
por: Kroemer, Guido, et al.
Publicado: (2021)

Mechanisms and Management of Immune Checkpoint Inhibitor-Related Cardiac Adverse Events
por: Kadowaki, Hiroshi, et al.
Publicado: (2021)

Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency
por: Manaka, Katsunori, et al.
Publicado: (2021)

Incidence, Clinical Characteristics, and Predictors of Cardiovascular Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
por: Isawa, Tsuyoshi, et al.
Publicado: (2022)

Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
por: Ushio, Ryota, et al.
Publicado: (2022)

Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor
por: Hamada, Kazuyuki, et al.
Publicado: (2023)

Immune checkpoint inhibitor-associated celiac disease
por: Badran, Yousef R, et al.
Publicado: (2020)

Immune checkpoint receptors: homeostatic regulators of immunity
por: Riva, Antonio, et al.
Publicado: (2018)

Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency
por: Katakura, Yukino, et al.
Publicado: (2021)

Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome
por: Kanie, Keitaro, et al.
Publicado: (2021)

Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
por: Ishihara, Masashi, et al.
Publicado: (2021)

Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
por: Nishimura, Tadashi, et al.
Publicado: (2022)

Clonal dynamics of circulating tumor DNA during immune checkpoint blockade therapy for melanoma
por: Takai, Erina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ntol3ktadgft6t7f7ah857njm